These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 890179)

  • 1. II. Particulate matter levels in large-volume injections: USP XIX method.
    Wente MA
    Bull Parenter Drug Assoc; 1977; 31(4):165-9. PubMed ID: 890179
    [No Abstract]   [Full Text] [Related]  

  • 2. USP perspectives on particle contamination of injectable products.
    Gallelli JF; Groves MJ
    J Parenter Sci Technol; 1993; 47(6):289-92. PubMed ID: 8120733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods for detection of particulate matter in large-volume perenterals.
    Blanchard J; Thompson CM; Schwartz JA
    Am J Hosp Pharm; 1976 Feb; 33(2):144-50. PubMed ID: 1258874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate matter standards for small-volume injections.
    Belson JJ
    Am J Hosp Pharm; 1986 Jun; 43(6):1527-8. PubMed ID: 3728492
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of acceptance criteria for particulate limits for small-volume parenteral products.
    Tsuji K; Lewis AR
    J Pharm Sci; 1978 Jan; 67(1):50-5. PubMed ID: 619115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of improved standardization methods and instrumentation in the USP particulate test for SVI.
    Barber TA; Lannis MD; Williams JG; Ryan JF
    J Parenter Sci Technol; 1990; 44(4):185-203. PubMed ID: 2213427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis.
    Schroeder HG; DeLuca PP
    Am J Hosp Pharm; 1976 Jun; 33(6):543-6. PubMed ID: 1274972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standards for particulate matter in all parenteral drug products.
    Jeffrey LP; Pinkus TF
    Am J Hosp Pharm; 1976 Sep; 33(9):879-80. PubMed ID: 984053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fifth supplement to the United States Pharmacopoeia XIX and National Formulary XIV].
    Montanari L
    Boll Chim Farm; 1979 Oct; 118(10):585-93. PubMed ID: 553525
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy of antimicrobial agents in parenteral products assessed by the USP XIX method compared to the USP XVIII method.
    Tan TG; Wilson RC
    J Parenter Drug Assoc; 1980; 34(6):431-5. PubMed ID: 7007603
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparison of the assay regulations for sterility testing between the USP XIX and the European Pharmacopoeia (author's transl)].
    Seyfarth H
    Zentralbl Bakteriol Orig B; 1975 Jul; 160(4-5):432-42. PubMed ID: 811006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 15. Particulate matter in four reconstituted cephalosporin injections.
    Kilarski DJ; Visconti JA; Frank SG
    Am J Hosp Pharm; 1983 Apr; 40(4):619-23. PubMed ID: 6846372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems of particulate matter in sterile solid products for injection.
    Hammer HF
    Bull Parenter Drug Assoc; 1974; 28(5):205-16. PubMed ID: 4421783
    [No Abstract]   [Full Text] [Related]  

  • 18. Particulate matter in small volume parenterals: evaluation of some technological and analytical aspects.
    Cirannni Signoretti E; Montanari I; Neri G; De Sena C; Alimonti S
    Boll Chim Farm; 1989 Feb; 128(2):65-70. PubMed ID: 2775519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative estimation of particulate matter in pharmaceutical preparations intended for intravenous administration.
    Bikhazi AB; Shiatis JA; Haddad AF
    J Pharm Sci; 1977 Feb; 66(2):181-6. PubMed ID: 839413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and scientific issues in the standardization of botanicals and their preparations. United States Pharmacopeia's dietary supplement verification program--a public health program.
    Srinivasan VS
    Life Sci; 2006 Mar; 78(18):2039-43. PubMed ID: 16516244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.